Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
FMY · Form NPORT-P · FIRST TRUST MORTGAGE INCOME FUND | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 83 · 8,212 total
SLMT: 6-K · ticker change
SLMT · 6-K · 2026-10-28
ULBI: 8-K · acquisition merger
ULBI · 8-K · 2026-10-28
CSTM: 10-Q · periodic report
CSTM · 10-Q · 2026-10-28
AMOD: S-3/A · shelf registration
AMOD · S-3/A · 2026-10-28
RBBN: 10-Q · periodic report
RBBN · 10-Q · 2026-10-28
HTB: 8-K · leadership change
HTB · 8-K · 2026-10-28
POOL: 10-Q · periodic report
POOL · 10-Q · 2026-10-28
AER: 6-K · earnings release
AER · 6-K · 2026-10-28
SLB: 10-Q · periodic report
SLB · 10-Q · 2026-10-28
SSP: 8-K · earnings release
SSP · 8-K · 2026-10-28
EQNR: 6-K · ownership disclosure
EQNR · 6-K · 2026-10-28
CLH: 10-Q · periodic report
CLH · 10-Q · 2026-10-28
E: 6-K · share repurchase
E · 6-K · 2026-10-28
STLA: 6-K · earnings release
STLA · 6-K · 2026-10-28
TGHL: 6-K · reverse split
TGHL · 6-K · 2026-10-28
ONB: 10-Q · periodic report
ONB · 10-Q · 2026-10-28
HSBC: 6-K · prospectus supplement
HSBC · 6-K · 2026-10-28
GSK: 6-K · earnings release
GSK · 6-K · 2026-10-28
WFF: 6-K · material agreement
WFF · 6-K · 2026-10-28
GCUMF: 6-K · ticker change
GCUMF · 6-K · 2026-10-28
TKC: 6-K · share repurchase
TKC · 6-K · 2026-10-28
MGM: SCHEDULE 13D/A · ownership disclosure
MGM · SCHEDULE 13D/A · 2026-10-28
WFF: 424B5 · prospectus supplement
WFF · 424B5 · 2026-10-28
INFY: 6-K · earnings release
INFY · 6-K · 2026-10-28
HYFT: 6-K · proxy statement
HYFT · 6-K · 2026-10-28
CFFN: 8-K · earnings release
CFFN · 8-K · 2026-10-28
GMAB: 6-K · clinical trial
GMAB · 6-K · 2026-10-28
APH: 8-K · earnings release
APH · 8-K · 2026-10-28
OSRH: 8-K · delisting
OSRH · 8-K · 2026-10-28
PRG: 10-Q · periodic report
PRG · 10-Q · 2026-10-28
NHTC: 10-Q · periodic report
NHTC · 10-Q · 2026-10-28
OMAB: 6-K · earnings release
OMAB · 6-K · 2026-10-28
OSS: 8-K · material agreement
OSS · 8-K · 2026-10-28
OSS: 424B5 · prospectus supplement
OSS · 424B5 · 2026-10-28
NHTC: 8-K · earnings release
NHTC · 8-K · 2026-10-28
AAPG: 6-K · other
AAPG · 6-K · 2026-10-28
DBX: 8-K · other
DBX · 8-K · 2026-10-28
PAG: 8-K · earnings release
PAG · 8-K · 2026-10-28
ARQT: 8-K · leadership change
ARQT · 8-K · 2026-10-28
AVTR: 10-Q · periodic report
AVTR · 10-Q · 2026-10-28
NOV: 8-K · earnings release
NOV · 8-K · 2026-10-28
MGM: 8-K · material agreement
MGM · 8-K · 2026-10-28
SKYA: 8-K · material agreement
SKYA · 8-K · 2026-10-28
WFC: 10-Q · other
WFC · 10-Q · 2026-10-28
ODFL: 8-K · earnings release
ODFL · 8-K · 2026-10-28
KYIV: 6-K · acquisition merger
KYIV · 6-K · 2026-10-28
TMUS: 8-K · leadership change
TMUS · 8-K · 2026-10-28
FCBC: 8-K · acquisition merger
FCBC · 8-K · 2026-10-28
CPAC: 6-K · acquisition merger
CPAC · 6-K · 2026-10-28
CDLR: 6-K · acquisition merger
CDLR · 6-K · 2026-10-28
JMSB: 8-K · earnings release
JMSB · 8-K · 2026-10-28
FMX: 6-K · earnings release
FMX · 6-K · 2026-10-28
VIR: 8-K · leadership change
VIR · 8-K · 2026-10-28
CHEF: 10-Q · periodic report
CHEF · 10-Q · 2026-10-28
AIB: 8-K · leadership change
AIB · 8-K · 2026-10-28
CHEF: 8-K · earnings release
CHEF · 8-K · 2026-10-28
ELVA: 6-K · material agreement
ELVA · 6-K · 2026-10-28
EVGN: 6-K · clinical trial
EVGN · 6-K · 2026-10-28
RNW: 6-K · amendment
RNW · 6-K · 2026-10-28
PRG: 8-K · earnings release
PRG · 8-K · 2026-10-28
FELE: 8-K · material agreement
FELE · 8-K · 2026-10-28
DAVA: 6-K · restatement
DAVA · 6-K · 2026-10-28
RNW: SCHEDULE 13D/A · ownership disclosure
RNW · SCHEDULE 13D/A · 2026-10-28
UL: 6-K · earnings release
UL · 6-K · 2026-10-28
CLH: 8-K · earnings release
CLH · 8-K · 2026-10-28
OLN: 8-K · debt financing
OLN · 8-K · 2026-10-28
ETSY: 10-Q · periodic report
ETSY · 10-Q · 2026-10-28
LNT: 8-K · debt financing
LNT · 8-K · 2026-10-28
ACMR: 8-K · earnings release
ACMR · 8-K · 2026-10-28
OSS: 8-K · earnings release
OSS · 8-K · 2026-10-28
GEVO: 8-K · leadership change
GEVO · 8-K · 2026-10-28
HUBB: 10-Q · periodic report
HUBB · 10-Q · 2026-10-28
ODYY: 10-K · periodic report
ODYY · 10-K · 2026-10-28
ORN: 8-K · earnings release
ORN · 8-K · 2026-10-28
BCAL: 8-K · earnings release
BCAL · 8-K · 2026-10-28
PRQR: 6-K · clinical trial
PRQR · 6-K · 2026-10-28
PYPD: 6-K · clinical trial
PYPD · 6-K · 2026-10-28
SHEN: 10-Q · periodic report
SHEN · 10-Q · 2026-10-28
CHRW: 8-K · earnings release
CHRW · 8-K · 2026-10-28
EAT: 8-K · earnings release
EAT · 8-K · 2026-10-28
ULCC: 10-Q · periodic report
ULCC · 10-Q · 2026-10-28
ENLV: 6-K · clinical trial
ENLV · 6-K · 2026-10-28
OSS: 10-Q · periodic report
OSS · 10-Q · 2026-10-28
FELE: 8-K · earnings release
FELE · 8-K · 2026-10-28
IMRN: 6-K · other
IMRN · 6-K · 2026-10-28
ACTU: 424B5 · prospectus supplement
ACTU · 424B5 · 2026-10-28
FMNB: 8-K · earnings release
FMNB · 8-K · 2026-10-28
ULCC: 8-K · earnings release
ULCC · 8-K · 2026-10-28
HNVR: 8-K · earnings release
HNVR · 8-K · 2026-10-28
ADSE: 6-K · other
ADSE · 6-K · 2026-10-28
BLDP: 6-K · other
BLDP · 6-K · 2026-10-28
HOPE: 8-K · earnings release
HOPE · 8-K · 2026-10-28
HTOO: 6-K · material agreement
HTOO · 6-K · 2026-10-28
VFC: 10-Q · periodic report
VFC · 10-Q · 2026-10-28
WING: 8-K · earnings release
WING · 8-K · 2026-10-28
MGPI: 10-Q · periodic report
MGPI · 10-Q · 2026-10-28
FCEL: 8-K · leadership change
FCEL · 8-K · 2026-10-28
WB: 6-K · other
WB · 6-K · 2026-10-28
BTI: 6-K · leadership change
BTI · 6-K · 2026-10-28
FTV: 10-Q · periodic report
FTV · 10-Q · 2026-10-28
1
2
3
4
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
83
Next ›
